Stockreport

Sangamo: Fabry Disease Gene Therapy Moves Forward With Positive FDA Regulatory Development [Seeking Alpha]

Sangamo Therapeutics, Inc.  (SGMO) 
Last sangamo therapeutics, inc. earnings: 2/28 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.sangamo.com
PDF Investing Group Leader Follow Summary Positive Type B meeting held with FDA, whereby U.S. agency stated that the phase 1/2 STAAR study using isaralgagene civaparv [Read more]